한국간담췌외과학회지 (Annals of Hepato-Biliary-Pancreatic Surgery)

  • 제26권1호
  • /
  • Pages.69-75
  • /
  • 2022
  • /
  • 2508-5778(pISSN)
  • /
  • 2508-5859(eISSN)
한국간담췌외과학회 (The Korean Association of Hepato-Biliary-Pancreatic Surgery)
권호 표지
DOI QR코드

DOI QR Code

Liver transplantation in pediatric patients with progressive familial intrahepatic cholestasis: Single center experience of seven cases

  • Jung-Man Namgoong (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Shin Hwang (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hyunhee Kwon (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Suhyeon Ha (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kyung Mo Kim (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seak Hee Oh (Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seung-Mo Hong (Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2021.08.02
  • 심사 : 2021.09.27
  • 발행 : 2022.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Backgrounds/Aims: Progressive familial intrahepatic cholestasis (PFIC) is an autosomal recessive inherited disease requiring liver transplantation (LT). The objective of this study was to investigate the clinicopathological features and posttransplant courses of seven LT recipients with PFIC. Methods: This was a retrospective single-center study of patients with PFIC who underwent LT from January 2013 to June 2020. Results: Two and five patients were diagnosed with PFIC type 1 and type 2, respectively. For all seven patients, age of PFIC onset was at birth. Jaundice was present in all cases. Mean pretransplant total and direct bilirubin levels were 16.1 ± 8.1 mg/dL and 12.4 ± 6.2 mg/dL, respectively. Median patient age and body weight at LT were 10 months and 7 kg, respectively. Types of donors were mothers of patients in four and deceased donors in three. All five patients with PFIC type 2 recovered uneventfully. One patient each with PFIC type 1 underwent retransplantation due to graft failure or died due to multi-organ failure. Overall graft and patient survival rates at five years were 66.7% and 83.3%, respectively. Bile salt export pump immunohistochemical staining showed normal canalicular expression in two patients with PFIC type 1, focal loss in two patients with PFIC type 2, and total loss in three patients with PFIC type 2. Conclusions: LT is currently the only effective treatment for PFIC-associated end-stage liver diseases. It is mandatory to perform regular follow-up due to the risk of complications including steatohepatitis, especially for patients with PFIC type 1.

키워드

참고문헌

  1. Nakanishi Y, Saxena R. Pathophysiology and diseases of the proximal pathways of the biliary system. Arch Pathol Lab Med 2015;139:858-866. 
  2. van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001;21:535-544. 
  3. de Vree JM, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998;95:282-287. 
  4. Clayton RJ, Iber FL, Ruebner BH, McKusick VA. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969;117:112-124. 
  5. Mehl A, Bohorquez H, Serrano MS, Galliano G, Reichman TW. Liver transplantation and the management of progressive familial intrahepatic cholestasis in children. World J Transplant 2016;6:278-290. 
  6. Jacquemin E. Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol 2012;36 Suppl 1:S26-S35. 
  7. Kang HJ, Hong SA, Oh SH, Kim KM, Yoo HW, Kim GH, et al. Progressive familial intrahepatic cholestasis in Korea: a clinicopathological study of five patients. J Pathol Transl Med 2019;53:253-260. 
  8. Namgoong JM, Hwang S, Song GW, Kim DY, Ha TY, Jung DH, et al. Pediatric liver transplantation with hyperreduced left lateral segment graft. Ann Hepatobiliary Pancreat Surg 2020;24:503-512. 
  9. Namgoong JM, Hwang S, Ahn CS, Jung DH, Park GC. Side-to-side portal vein reconstruction for infant-to-infant deceased donor whole liver transplantation: report of 2 cases with video. Ann Hepatobiliary Pancreat Surg 2020;24:301-304. 
  10. Rhee ES, Kim YB, Lee S, Oh SH, Lee BH, Kim KM, et al. Novel ATP8B1 gene mutations in a child with progressive familial intrahepatic cholestasis type 1. Pediatr Gastroenterol Hepatol Nutr 2019;22:479-486. 
  11. Aydogdu S, Cakir M, Arikan C, Tumgor G, Yuksekkaya HA, Yilmaz F, et al. Liver transplantation for progressive familial intrahepatic cholestasis: clinical and histopathological findings, outcome and impact on growth. Pediatr Transplant 2007;11:634-640. 
  12. Liu Y, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG. Liver transplantation for progressive familial intrahepatic cholestasis. Ann Transplant 2018;23:666-673. 
  13. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009;4:1. 
  14. Nemesanszky E, Lott JA. Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin Chem 1985;31:797-803. 
  15. Oude Elferink RP, Paulusma CC, Groen AK. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology 2006;130:908-925. 
  16. Klomp LW, Vargas JC, van Mil SW, Pawlikowska L, Strautnieks SS, van Eijk MJ, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004;40:27-38. 
  17. Alissa FT, Jaffe R, Shneider BL. Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 2008;46:241-252. 
  18. Liu LY, Wang XH, Wang ZL, Zhu QR, Wang JS. Characterization of ATP8B1 gene mutations and a hot-linked mutation found in Chinese children with progressive intrahepatic cholestasis and low GGT. J Pediatr Gastroenterol Nutr 2010;50:179-183. 
  19. Gonzales E, Spraul A, Jacquemin E. Clinical utility gene card for: progressive familial intrahepatic cholestasis type 2. Eur J Hum Genet 2014;22:572. 
  20. Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997;25:519-523. 
  21. Amer S, Hajira A. A comprehensive review of progressive familial intrahepatic cholestasis (PFIC): genetic disorders of hepatocanalicular transporters. Gastroenterology Res 2014;7:39-43. 
  22. Hori T, Egawa H, Miyagawa-Hayashino A, Yorifuji T, Yonekawa Y, Nguyen JH, et al. Living-donor liver transplantation for progressive familial intrahepatic cholestasis. World J Surg 2011;35:393-402. 
  23. Hori T, Egawa H, Takada Y, Ueda M, Oike F, Ogura Y, et al. Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan. Clin Transplant 2011;25:776-785. 
  24. Englert C, Grabhorn E, Richter A, Rogiers X, Burdelski M, Ganschow R. Liver transplantation in children with progressive familial intrahepatic cholestasis. Transplantation 2007;84:1361-1363. 
  25. Maggiore G, Gonzales E, Sciveres M, Redon MJ, Grosse B, Stieger B, et al. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2. J Hepatol 2010;53:981-986. 
  26. Sindhi R, Rohan V, Bukowinski A, Tadros S, de Ville de Goyet J, Rapkin L, et al. Liver transplantation for pediatric liver cancer. Cancers (Basel) 2020;12:720. 
  27. Namgoong JM, Hwang S, Kim DY, Ahn CS, Kwon H, Ha S, et al. Living donor liver transplantation in an infant patient with progressive familial intrahepatic cholestasis along with hepatocellular carcinoma: a case report. Korean J Transpl 2021. https://doi.org/10.4285/kjt.21.0007 [in press] 
  28. Esquivel CO, Gutierrez C, Cox KL, Garcia-Kennedy R, Berquist W, Concepcion W. Hepatocellular carcinoma and liver cell dysplasia in children with chronic liver disease. J Pediatr Surg 1994;29:1465-1469. 
  29. Brunati A, Feruzi Z, Sokal E, Smets F, Fervaille C, Gosseye S, et al. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation. Pediatr Transplant 2007;11:117-119. 
  30. Iida T, Zendejas IR, Kayler LK, Magliocca JF, Kim RD, Hemming AW, et al. Hepatocellular carcinoma in a 10-month-old biliary atresia child. Pediatr Transplant 2009;13:1048-1049. 
  31. Kim JM, Lee SK, Kwon CH, Joh JW, Choe YH, Park CK. Hepatocellular carcinoma in an infant with biliary atresia younger than 1 year. J Pediatr Surg 2012;47:819-821.